Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 20/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5634399 | 0.87 | MCHR1 (0.75) | MCHR1 | |
| SCHEMBL4876379 | 0.86 | MCHR1 (0.62) | MCHR1 | |
| SCHEMBL5256633 | 0.86 | MCHR1 (0.73) | MCHR1 | |
| SCHEMBL4878488 | 0.85 | MCHR1 (0.61) | MCHR1 | |
| SCHEMBL5636058 | 0.85 | MCHR1 (0.63) | MCHR1 | |
| SCHEMBL5635417 | 0.85 | MCHR1 (0.63) | MCHR1 | |
| SCHEMBL13912310 | 0.84 | MCHR1 (0.60) | MCHR1 | |
| SCHEMBL13912318 | 0.84 | MCHR1 (0.60) | MCHR1 | |
| SCHEMBL5634744 | 0.83 | MCHR1 (0.63) | MCHR1 | |
| SCHEMBL12838152 | 0.83 | MCHR1 (0.69) | MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070078125-A1 | Arylamine mch r1 antagonists | GLAXO GROUP LIMITED | 2007-04-05 | — | — | US | disclosed |
| US-20070078125-A1 | Arylamine mch r1 antagonists | GLAXO GROUP LIMITED | 2007-04-05 | — | — | US | disclosed |
| US-20070078125-A1 | Arylamine mch r1 antagonists | GLAXO GROUP LIMITED | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078125-A1 | Arylamine mch r1 antagonists | MCHR1, MCHR2, MC1R | MCHR1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.